Multi-Omics Platform
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
500
NCT05982561
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Phase: N/A
Role: Lead Sponsor
Start: Jul 26, 2023
Completion: Dec 31, 2025
Loading map...